Collaborations Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Collaborations Pharmaceuticals has a total of 12 patents globally, out of which 2 have been granted. Of these 12 patents, more than 75% patents are active. The United States of America is where Collaborations Pharmaceuticals has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Collaborations Pharmaceuticals.

Collaborations Pharmaceuticals was founded in 2015. Collaborations Pharmaceuticals is a preclinical pipeline company that develops novel therapies and conducts research and development for uncommon and undertreated diseases.

Do read about some of the most popular patents of Collaborations Pharmaceuticals which have been covered by us in this article and also you can find Collaborations Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Collaborations Pharmaceuticals patent portfolio.

How many patents does Collaborations Pharmaceuticals have?

Collaborations Pharmaceuticals has a total of 12 patents globally. These patents belong to 7 unique patent families. Out of 12 patents, 9 patents are active.

How Many Patents did Collaborations Pharmaceuticals File Every Year?

Collaborations Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCollaborations Pharmaceuticals Applications FiledCollaborations Pharmaceuticals Patents Granted
20222
20214
202051
201811

How many Collaborations Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Collaborations Pharmaceuticals Patent Portfolio

How Many Patents did Collaborations Pharmaceuticals File in Different Countries?

Collaborations Pharmaceuticals Worldwide Patent Filing

Countries in which Collaborations Pharmaceuticals Filed Patents

CountryPatent
United States Of America4
Europe2
Canada1

Where are Research Centers of Collaborations Pharmaceuticals Patents Located?

R&D Centres of Collaborations Pharmaceuticals

10 Best Collaborations Pharmaceuticals Patents

WO2022061019A1, WO2021062189A1 is the most popular patent in the Collaborations Pharmaceuticals portfolio and it has received 1 citation.

What Percentage of Collaborations Pharmaceuticals US Patent Applications Were Granted?

Collaborations Pharmaceuticals (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.

Below are the key stats of Collaborations Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Collaborations Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Epa Bozicevic Field & Francis Llp1100%
Jenkins Wilson Taylor & Hunt P A10%

List of Collaborations Pharmaceuticals patents

Collaborations Pharmaceuticals PatentsTitle
US11696914B1Use Of Pyronaridine, Tilorone, And Quinacrine Against Marburg Virus And Other Virus Infections
US11382875B2Methods And Compositions For Modulating Β-Amyloid/Α7-Nachr Interactions
US20230330045A1The Antiviral Drug Tilorone Is A Potent And Selective Inhibitor Of Acetylcholinesterase
US20220298149A1Isoxazole-3-Carboxamide Derivatives And Their Use For Treatment Of Diseases Caused By Virus Infection
EP4025212A4Isoxazole-3-Carboxamide Derivatives And Their Use For Treatment Of Diseases Caused By Virus Infection
EP4208257A1The Antiviral Drug Tilorone Is A Potent And Selective Inhibitor Of Acetylcholinesterase
WO2023114945A3Vandetanib Reduces Inflammatory Cytokines And Ameliorates Covid-19
WO2023128786A1New Antiviral Triazole Derivatives, Their Synthesis And Their Use For Treatment Of Mammalian Viral Infections
CA3152534A1Isoxazole-3-Carboxamide Derivatives And Their Use For Treatment Of Diseases Caused By Virus Infection
WO2022155597A3Uv-Vis Spectra Prediction
WO2022061019A1The Antiviral Drug Tilorone Is A Potent And Selective Inhibitor Of Acetylcholinesterase
WO2021062189A1Isoxazole-3-Carboxamide Derivatives And Their Use For Treatment Of Diseases Caused By Virus Infection

What are Collaborations Pharmaceuticals key innovation segments?

What Technologies are Covered by Collaborations Pharmaceuticals?

The chart below distributes patents filed by Collaborations Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Collaborations Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Collaborations Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Collaborations Pharmaceuticals?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.